These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 7377418)
1. Drug product selection: the Florida experience. Vuturo GJ; Krischer JP; McCormick WC Am J Public Health; 1980 May; 70(5):479-84. PubMed ID: 7377418 [TBL] [Abstract][Full Text] [Related]
2. The irony of drug product selection. Wertheimer AI Am J Public Health; 1980 May; 70(5):473. PubMed ID: 7377416 [No Abstract] [Full Text] [Related]
3. Evaluation of economic effects of drug product selection legislation. Goldberg T; DeVito CA; Smith D; Stano M; Vidis JS; Moore WE; Dickson WM Med Care; 1979 Apr; 17(4):411-9. PubMed ID: 431151 [TBL] [Abstract][Full Text] [Related]
4. Potential and actual drug product selection rates in Florida. Vuturo GJ; McCormick WC; Krischer JP Contemp Pharm Pract; 1980; 3(3):163-70. PubMed ID: 10247872 [TBL] [Abstract][Full Text] [Related]
5. Prescription prices under the New York generic substitution law. Francetić I; Lasagna L; Weintraub M; Karch FE Ann Intern Med; 1980 Mar; 92(3):419-23. PubMed ID: 7356236 [TBL] [Abstract][Full Text] [Related]
6. Drug product selection: the Florida experience revisited. Clouse EH; McCormick WC; Angorn RA; Kimberlin CL; Bradham DD Am J Public Health; 1985 Mar; 75(3):283-4. PubMed ID: 3976956 [TBL] [Abstract][Full Text] [Related]
7. Drug product selection in Illinois: the first year's experience. Stewart JE; Grussing PG; Purohit AA Med Care; 1982 Aug; 20(8):831-42. PubMed ID: 7109752 [TBL] [Abstract][Full Text] [Related]
8. Gift giving. Raszkowski RR S D J Med; 2002 Dec; 55(12):513-4. PubMed ID: 12516357 [No Abstract] [Full Text] [Related]
9. Maximum allowable cost: can the government control drug costs? Smith MI; Wertheimer AI J Health Polit Policy Law; 1979; 4(2):155-75. PubMed ID: 385712 [TBL] [Abstract][Full Text] [Related]
10. Savings from generic prescriptions. A study of 33 pharmacies in Rochester, New York. Horvitz RA; Morgan JP; Fleckenstein L Ann Intern Med; 1975 May; 82(5):601-7. PubMed ID: 166584 [TBL] [Abstract][Full Text] [Related]
11. The effects of competition on prescription-drug-product substitution. Kralewski JE; Pitt L; Dowd B N Engl J Med; 1983 Jul; 309(4):213-6. PubMed ID: 6866035 [TBL] [Abstract][Full Text] [Related]
12. Attitudes of pharmacists and physicians toward Florida's drug product selection law. Vuturo GJ; McCormick WC; Krischer JP Contemp Pharm Pract; 1980; 3(3):156-62. PubMed ID: 10247871 [TBL] [Abstract][Full Text] [Related]
13. Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries. Lewis JH; Schonlau M; Muñoz JA; Asch SM; Rosen MR; Yang H; Escarce JJ N Engl J Med; 2002 Mar; 346(11):830-5. PubMed ID: 11893795 [TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical drawbacks. Meyers D Med J Aust; 1979 Apr; 1(8):344. PubMed ID: 449826 [No Abstract] [Full Text] [Related]
15. Prescription pricing across Canada (Part II). Archer F CPJ; 1984 Sep; 117(9):434-5. PubMed ID: 10268225 [TBL] [Abstract][Full Text] [Related]
16. Impact of drug substitution legislation--implications for continuing education for Michigan pharmacists. Moore WE; Goldberg T; Aldridge GW; Vidis JS; DeVito CA; Dickson WM Contemp Pharm Pract; 1980; 3(2):100-3. PubMed ID: 10246108 [TBL] [Abstract][Full Text] [Related]
17. Cost and price of comparable branded and generic pharmaceuticals. Bloom BS; Wierz DJ; Pauly MV JAMA; 1986 Nov; 256(18):2523-30. PubMed ID: 3773152 [TBL] [Abstract][Full Text] [Related]
18. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use. Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092 [TBL] [Abstract][Full Text] [Related]
19. Forces and direction of drug product selection legislation. Stewart JE Med Mark Media; 1979 Jun; 14(6):34-6, 38-9. PubMed ID: 10242281 [No Abstract] [Full Text] [Related]